Three areas of expertise under one roof to lead projects to success
Read More
Your pharmaceutical exploitant to market your products to French patients
Read More
Your distributor for in house storage under qualified temperature conditions & product dispatch
Read More
Your manufacturer to put packaging in compliance with local requirements
Read More
CEVIDRA
Exploitant, Distributor, Manufacturer & Importer : Ensuring access for medicines to the French market from Early Access Program to Post-Market Approval.
Exploitant
Cevidra has the status of pharmaceutical exploitant for the marketing of medicinal products in France.
Read More
Distributor
Cevidra is the owner and distributor of the products it markets and can also act on behalf of MAH to store & distribute their products.
Read More
Manufacturer/Importer
Cevidra performs batch release of manufactured or imported medicinal products.
Read MorePARTNER IN YOUR PROJECTS
Cevidra proposes a unique & integrated offer unrivaled in France by leveraging its complementary activities to bring products under ATU (Temporary Use Authorization) or MA (Marketing Authorization) to the French market with a strong expertise in medicines for rare or orphan diseases.
OUR VALUES
CEVIDRA is dedicated daily to its partner & committed to improving the trust of suppliers, patients, families and Health Care Professionals through a culture oriented towards 4 key values, each carried by all of our employees:
- Transparency and communication
- Respect and Listening
- Valuation of knowledge and competence
- Integrity
« Cevidra is a family-owned pharmaceutical company with a clear focus on top-line projects. We are faster, better, and more experienced than anyone else in managing complete processes for Early Access or Compassionate Use in France. We do this by optimizing the regulatory and marketing strategies, we manage internally the manufacturing from labelling to batch release as well as the distribution and sales with hospitals and retail pharmacies. We deliver measurable revenue on projects and market growth for our partners from Europe and others regions. »
Stéphane Destaing, President of CEVIDRA
Our partners
NEWS
Cevidra participates in the webinar organised by the HAS about the early access for medicines in France
This year, the ISTH (International Society on Thrombosis and Haemostasis) is offering a session dedicated to factor X deficiency.
Cevidra participates in the Congress organised by GLUT1D : one day dedicated to metabolic disorders.
Cevidra signed new distribution agreements with two companies (BPL & Kedrion) dedicated to blood derivated products. Cevidra built up its known-how over the years and through projects.
Over the years, Cevidra has always shown its willingness to develop, diversify and improve its service offer to accompany you further in your projects.